Rapidly enlarging ACTIN::MITF rearranged clear cell tumour with melanocytic differentiation

Abstract excerpt

Sir: MITF pathway-driven cutaneous mesenchymal neoplasms with melanocytic differentiation encompass three newly characterised tumour entities, distinguished by ACTIN::MITF, CRTC1::TRIM11 and MITF::CREM gene fusions. To date, eight cases of ACTIN::MITF rearranged clear cell tumours with melanocytic differentiation have been documented, seven of which were reported in a 2021 case series by Fouchardiere et al.1, 2...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Renal cell carcinoma treatment
• Share to Tuberous Sclerosis Complex Research
• Share to Vascular Tumors and Angiosarcomas